Serial 97392075
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97392075
- Registration number
- 7663349
- Mark type
- Design / logo
- Filed
- 02 May 2022
- Published for opposition
- 07 Mar 2023
- Registered
- 21 Jan 2025
- Attorney of record
- Carissa L. Weiss
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders
- Class 035 — Advertising and business services: Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals
- Class 044 — Medical, beauty and agricultural services: Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders
Owner
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Oct 2024 — ASSIGNED TO LIE
- 06 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jul 2024 — NON-FINAL ACTION E-MAILED
- 31 Jul 2024 — SU - NON-FINAL ACTION - WRITTEN
- 09 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 31 May 2024 — USE AMENDMENT FILED
- 10 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 May 2024 — TEAS STATEMENT OF USE RECEIVED